These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 13588366)

  • 1. Growth of mouse ascites tumor cells in diffusion chambers. I. Studies of growth rate of cells and of the rate of entry of antibody.
    AMOS DB; WAKEFIELD JD
    J Natl Cancer Inst; 1958 Oct; 21(4):657-70. PubMed ID: 13588366
    [No Abstract]   [Full Text] [Related]  

  • 2. Growth of mouse ascites tumor cells in diffusion chambers. II. Lysis and growth inhibition by diffusible iso-antibody.
    AMOS DB; WAKEFIELD JD
    J Natl Cancer Inst; 1959 Jun; 22(6):1077-92. PubMed ID: 13665335
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on mouse lymphomas. III. Behavior of tumor- and non-tumor-cell populations during growth of three ascites lymphomas.
    SHELTON E; RICE ME
    J Natl Cancer Inst; 1958 Jul; 21(1):163-91. PubMed ID: 13564198
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on growth and regression of Ehrlich mouse ascites tumor heterotransplants.
    HORAVA A; VON HAAM E
    Cancer Res; 1958 Aug; 18(7):753-9. PubMed ID: 13573338
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experimental demonstration of a cytotoxic and an anticytotoxic antibody against mice ascites tumor and their effect on tumor growth].
    RUBNER O
    Z Immun exp ther; 1958; 116(5-6):453-65. PubMed ID: 13616495
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experimental studies on anti-tumor effects of BLC-modified tumor cell vaccine combined with cisplatin].
    Zou CH; Tian L; Wei YQ; Zhao X; Kan B; Yang JL; Mao YQ; Wen YJ; Li J; Deng HX
    Ai Zheng; 2004 Jan; 23(1):1-7. PubMed ID: 14720366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on mouse lymphomas. II. Behavior of three lymphomas in diffusion chambers in relation to their invasive capacity in the host.
    SHELTON E; RICH ME
    J Natl Cancer Inst; 1958 Jul; 21(1):137-61. PubMed ID: 13564197
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experimental metastasis formation by means of intravenous transplantation of tumor cells: studies by the Yoshida sarcoma and the rat ascites hepatomas].
    TAKITA J
    Tohoku Igaku Zasshi; 1962 Apr; 65():384-401. PubMed ID: 13984721
    [No Abstract]   [Full Text] [Related]  

  • 9. Growth and implantation of free tumor cells in ascites tumors of mice previously given sex hormones.
    GOLDIE H; WALKER M; CHAMBERS K; ROBERTS V
    Cancer Res; 1959 Jan; 19(1):28-32. PubMed ID: 13618880
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prolonged heterogenous transplantation of mouse tumor in rats. I. Studies on biological properties of mouse ascites adenocarcinoma during serial transplantation in rats].
    PODOPLELOV II
    Biull Eksp Biol Med; 1957 Jun; 43(6):63-5. PubMed ID: 13488993
    [No Abstract]   [Full Text] [Related]  

  • 11. Paracrine action of sFLT-1 secreted by stably-transfected Ehrlich ascites tumor cells and therapy using sFLT-1 inhibits ascites tumor growth in vivo.
    Ramachandra S; D'Souza SS; Gururaj AE; Shaila MS; Salimath BP
    J Gene Med; 2009 May; 11(5):422-34. PubMed ID: 19266483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative studies of the growth response of the Krebs ascites tumor.
    PATT HM; BLACKFORD ME
    Cancer Res; 1954 Jun; 14(5):391-6. PubMed ID: 13160969
    [No Abstract]   [Full Text] [Related]  

  • 13. Antitumor and apoptosis promoting properties of atorvastatin, an inhibitor of HMG-CoA reductase, against Dalton's Lymphoma Ascites tumor in mice.
    Ajith TA; Anu V; Riji T
    J Exp Ther Oncol; 2008; 7(4):291-8. PubMed ID: 19227009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of ascites tumor cells. I. Rate of glycolysis and competitive utilization of fructose, mannose, and glucose.
    YUSHOK WD
    Cancer Res; 1959 Jan; 19(1):104-11. PubMed ID: 13618894
    [No Abstract]   [Full Text] [Related]  

  • 15. VEGF antisense therapy inhibits tumor growth and improves survival in experimental pancreatic cancer.
    Hotz HG; Hines OJ; Masood R; Hotz B; Foitzik T; Buhr HJ; Gill PS; Reber HA
    Surgery; 2005 Feb; 137(2):192-9. PubMed ID: 15674201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative electron microscopic study on Ehrlich ascites tumor cells, Yoshida sarcoma cells, and human cancerous peritonitis ascites cells.
    YASUZUMI G; SUGIHARA R
    Cancer Res; 1958 Nov; 18(10):1167-70. PubMed ID: 13596958
    [No Abstract]   [Full Text] [Related]  

  • 17. Quantitative studies on the multiplication of neoplastic cells in vivo. II. Growth curves of three ascites lymphomas.
    REVESZ L; KLEIN G
    J Natl Cancer Inst; 1954 Oct; 15(2):253-73. PubMed ID: 13233882
    [No Abstract]   [Full Text] [Related]  

  • 18. MATURATION OF TRANSPLANTABLE LEUKEMIC CELLS CULTIVATED IN VIVO IN DIFFUSION CHAMBERS.
    PARRISH W; KLEINFELD RG
    Cancer Res; 1963 Sep; 23():1164-8. PubMed ID: 14070371
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic efficacy and tumor dose estimations in radioimmunotherapy of intraperitoneally growing OVCAR-3 cells in nude mice with (211)At-labeled monoclonal antibody MX35.
    Elgqvist J; Andersson H; Bäck T; Hultborn R; Jensen H; Karlsson B; Lindegren S; Palm S; Warnhammar E; Jacobsson L
    J Nucl Med; 2005 Nov; 46(11):1907-15. PubMed ID: 16269606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Trypsin resistance of natural and heat-treated cells; studies with leukocytes and ascites tumor cells of mice].
    SEELICH F; KECK K
    Z Zellforsch Mikrosk Anat; 1955; 41(5):474-80. PubMed ID: 14387134
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.